 | Resveratrol | IC50 | 913.0 [1] |
| Resveratrol | Ki | 88.0 [1] |
 | Melatonin | IC50 | 6600.0 [1], 11300.0 [2] |
| Melatonin | Ki | 27.6 [1], 56.9 [2] |
 | Imatinib | IC50 | 43.0 [1], 82.0 [2], 400.0 [3] |
| Imatinib | Ki | 39.0 [1] |
 | Dabigatran | IC50 | 10000.0 [1], 11000.0 [2] |
| Dabigatran | Ki | 60000.0 [1] |
 | 5-Methoxycarbonylamino-N-acetyltryptamine | IC50 | 2.7 [1], 57.54 [2], 58.0 [3] |
 | N-[2-(5-Methoxy-1-methyl-1H-indol-3-yl)-ethyl]-acetamide | IC50 | 2.82 [1], 5700.0 [2] |
| N-[2-(5-Methoxy-1-methyl-1H-indol-3-yl)-ethyl]-acetamide | Ki | 2.8 [1] |
 | Acetamide,n-[2-(2-iodo-5-methoxy-1-methyl-4-nitro-1h-indol-3-yl)ethyl]- | IC50 | 0.13 [1] |
| Acetamide,n-[2-(2-iodo-5-methoxy-1-methyl-4-nitro-1h-indol-3-yl)ethyl]- | Ki | 0.13 [1], 0.3 [2] |
 | Dabigatran ethyl ester | IC50 | 800.0 [1], 1500.0 [2] |
| Dabigatran ethyl ester | Ki | 900.0 [1] |
 | Acetic acid;4-[5-(4-carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide | IC50 | 35.0 [1], 72.0 [2], 630.0 [3] |
 | Acetic acid;4-(5-phenylfuran-2-yl)benzenecarboximidamide | IC50 | 68.0 [1], 139.0 [2], 140.0 [3] |
 | Nilotinib | IC50 | 381.0 [1], 1800.0 [2] |
 | 2-Iodomelatonin | IC50 | 1100.0 [1] |
| 2-Iodomelatonin | Ki | 6.5 [1] |
 | 5-((2-(Diethylamino)ethyl)amino)-8-hydroxy-6H-imidazo[4,5,1-de]acridin-6-one | IC50 | 126.0 [1], 148.0 [2] |
 | 5-((2-(Diethylamino)ethyl)amino)-8-hydroxy-1-methyl-6H-imidazo(4,5,1-de)acidin-6-one | IC50 | 16.0 [1], 54.0 [2] |
 | 10-[2-(Dimethylamino)ethylamino]-5-hydroxy-1,14-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-2(7),3,5,9,11,13(16),14-heptaen-8-one | IC50 | 83.0 [1], 296.0 [2] |
 | N-[2-(5-Methoxy-1-methyl-4-nitro-1H-indol-3-yl)-ethyl]-acetamide | IC50 | 0.31 [1] |
| N-[2-(5-Methoxy-1-methyl-4-nitro-1H-indol-3-yl)-ethyl]-acetamide | Ki | 0.31 [1] |
 | 5-((2-(Dimethylamino)ethyl)amino)-8-hydroxy-1-methyl-6H-imidazo(4,5,1-de)acridin-6-one | IC50 | 50.0 [1], 90.0 [2] |
 | 10-[2-(Dimethylamino)ethylamino]-1,14-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-2,4,6,9,11,13(16),14-heptaen-8-one | IC50 | 115.0 [1], 830.0 [2] |
 | Acetamide,n-[2-(2-iodo-5-methoxy-4-nitro-1h-indol-3-yl)ethyl]- | IC50 | 0.2 [1] |
| Acetamide,n-[2-(2-iodo-5-methoxy-4-nitro-1h-indol-3-yl)ethyl]- | Ki | 0.18 [1] |
 | N-[2-(5-Methoxy-4-nitro-1H-indol-3-yl)ethyl]acetamide | IC50 | 1.2 [1] |
| N-[2-(5-Methoxy-4-nitro-1H-indol-3-yl)ethyl]acetamide | Ki | 1.1 [1] |
 | Acetamide,n-[2-(2-iodo-5-methoxy-1-methyl-1h-indol-3-yl)ethyl]- | IC50 | 0.09 [1] |
| Acetamide,n-[2-(2-iodo-5-methoxy-1-methyl-1h-indol-3-yl)ethyl]- | Ki | 0.09 [1] |
 | 5-{[2-(Dimethylamino)ethyl]amino}-8-Methoxy-6h-Imidazo[4,5,1-De]acridin-6-One | IC50 | 59.0 [1], 3200.0 [2] |
 | N-(2-(7-Sulfamoylnaphthalen-1-yl)ethyl)acetamide | IC50 | 32.0 [1], 32.36 [2] |
 | N-(2-(7-(N-Methylsulfamoyl)naphthalen-1-yl)ethyl)furan-2-carboxamide | IC50 | 9.1 [1], 9.12 [2] |
 | N-(2-(7-(Methylsulfonyl)naphthalen-1-yl)ethyl)acetamide | IC50 | 20.89 [1], 21.0 [2] |
 | 10-[2-(Dimethylamino)ethylamino]-15-methyl-1,14-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-2,4,6,9,11,13(16),14-heptaen-8-one | IC50 | 90.0 [1], 323.0 [2] |
 | N-[3-(Cyanomethyl)-2-oxo-2,3-dihydro-1H-indol-5-yl]acetamide | IC50 | 14100.0 [1] |
 | N-[2-(5-Acetamido-3-hydroxy-2-oxo-1H-indol-3-yl)ethyl]acetamide | IC50 | 200.0 [1] |
 | N-[2-(5-Acetamido-2-oxo-1,3-dihydroindol-3-yl)ethyl]acetamide | IC50 | 20700.0 [1] |
 | N-[3-(Cyanomethyl)-1-methyl-2-oxo-3H-indol-5-yl]acetamide | IC50 | 7000.0 [1] |
 | N-(2-(7-(Methylsulfinyl)naphthalen-1-yl)ethyl)acetamide | IC50 | 37.0 [1], 37.15 [2] |
 | N-(2-(7-(Methylthio)naphthalen-1-yl)ethyl)acetamide | IC50 | 18.0 [1], 18.2 [2] |
 | Acetic acid;4-[5-(4-ethylphenyl)furan-2-yl]benzenecarboximidamide | IC50 | 202.0 [1], 312.0 [2] |
 | Acetic acid;4-[5-(4-methoxyphenyl)furan-2-yl]benzenecarboximidamide | IC50 | 107.0 [1], 141.0 [2] |
 | Acetic acid;4-[5-(4-tert-butylphenyl)furan-2-yl]benzenecarboximidamide | IC50 | 509.9 [1], 712.0 [2] |
 | Acetic acid;4-[5-(3-nitrophenyl)furan-2-yl]benzenecarboximidamide | IC50 | 14.5 [1], 28.0 [2] |
 | Acetic acid;4-[5-(4-nitrophenyl)furan-2-yl]benzenecarboximidamide | IC50 | 15.2 [1], 24.0 [2] |
 | Acetic acid;4-(5-phenyl-1H-pyrrol-2-yl)benzenecarboximidamide | IC50 | 332.0 [1], 832.0 [2] |
 | Acetic acid;4-(1-methyl-5-phenylpyrrol-2-yl)benzenecarboximidamide | IC50 | 410.0 [1], 943.0 [2] |
 | 2-[(5-Methoxy-8-oxo-1,14-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-2(7),3,5,9,11,13(16),14-heptaen-10-yl)amino]-N,N-dimethylethanamine oxide | IC50 | 14.0 [1], 98.0 [2] |
 | 4-[5-(3-Fluorophenyl)furan-2-yl]benzenecarboximidamide | IC50 | 98.0 [1], 111.0 [2] |
 | 4-[5-(4-Fluorophenyl)furan-2-yl]benzenecarboximidamide | IC50 | 505.0 [1], 836.0 [2] |
 | 4-[5-(4-Bromophenyl)furan-2-yl]benzenecarboximidamide | IC50 | 27.0 [1], 185.0 [2] |
 | 4-[5-(4-Methylphenyl)furan-2-yl]benzenecarboximidamide | IC50 | 72.0 [1], 110.0 [2] |
 | Chloroquine | IC50 | 1500.0 [1] |
 | Prazosin | IC50 | 7.8 [1] |
 | Primaquine | IC50 | 7500.0 [1] |
 | Pterostilbene | IC50 | 5100.0 [1] |
 | Furamidine | IC50 | 35.0 [1] |
 | (E)-3,5,4'-Trimethoxystilbene | IC50 | 14600.0 [1] |
 | Pseudoisocyanine | IC50 | 2700.0 [1] |
 | 1,3-Naphthalenediol | IC50 | 3300.0 [1] |
 | 4-(4-Butylpiperidin-1-yl)-1-o-tolylbutan-1-one | Ki | 1000.0 [1] |
 | 1-Methoxyphenazine | IC50 | 31100.0 [1] |
 | 4-Methylquinolin-2-ol | IC50 | 500000.0 [1] |
 | (E)-3,3',4,5'-Tetramethoxystilbene | IC50 | 37100.0 [1] |
 | 6,8-Diamino-7-Chloro-1-Methyl-2-Oxo-1,2-Dihydropyrrolo[4,3,2-De]quinoline-4-Carboxamide | IC50 | 61.0 [1] |
 | N-(2-(5-Methoxybenzofuran-3-yl)ethyl)acetamide | IC50 | 64.57 [1] |
 | 3,5-Dimethoxy-4'-fluorostilbene | IC50 | 4600.0 [1] |
 | 4-(4-Hydroxystyryl)benzene-1,2-diol | IC50 | 6000.0 [1] |
 | (E)-3'-Hydroxy-3,5,4'-trimethoxystilbene | IC50 | 15000.0 [1] |
 | 1,4-Dimethylquinolin-2(1h)-one | IC50 | 18200.0 [1] |
 | 2-Methoxyphenazine | IC50 | 15300.0 [1] |
 | Casimiroin | IC50 | 54100.0 [1] |
 | 4-[2-(3,5-Dimethoxyphenyl)ethenyl]benzeneamine | IC50 | 1700.0 [1] |
 | 1-Methoxy-7,8-dimethylphenazine | IC50 | 11700.0 [1] |
 | 3,4-Dimethoxy-N-(2-naphthyl)benzamide | IC50 | 5500.0 [1] |
 | Propanamide, N-(2-(7-methoxy-1-naphthalenyl)ethyl)-2-methyl- | IC50 | 43.65 [1] |
 | 3,4-Dimethyl-2,5-bis(4-amidinophenyl)furan | IC50 | 50.0 [1] |
 | N-[1-[3-(3-Oxo-1,4-benzoxazin-4-yl)propyl]piperidin-4-yl]-2-phenylacetamide | Ki | 1000.0 [1] |
 | 5,7-Dihydroxy-2-(4-hydroxyphenyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one | IC50 | 3840.0 [1] |
 | 3,4-Dihydroxy-4'-methoxystilbene | IC50 | 9300.0 [1] |
 | 2-Chloromelatonin | IC50 | 13000.0 [1] |
 | 5,8-Dimethoxy-4-methylquinolin-2(1H)-one | IC50 | 10800.0 [1] |
 | Benzamide, N-(2-(7-methoxy-1-naphthalenyl)ethyl)- | IC50 | 28.84 [1] |
 | 10-[2-(Diethylamino)ethylamino]-8-hydroxy-4,5-dimethoxy-1,14-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-2,4,7,9,11,13(16),14-heptaen-6-one | IC50 | 6.0 [1] |
 | 10-[2-(Diethylamino)ethylamino]-8-hydroxy-1,14-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-2,5,7,9,11,13(16),14-heptaen-4-one | IC50 | 953.0 [1] |
 | 10-[2-(Diethylamino)ethylamino]-5-methoxy-1,14-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-2(7),3,5,9,11,13(16),14-heptaen-8-one | IC50 | 1000.0 [1] |
 | 10-[2-(Dimethylamino)ethylamino]-1,14,15-triazatetracyclo[7.6.1.02,7.013,16]hexadeca-2,4,6,9,11,13(16),14-heptaen-8-one | IC50 | 1833.0 [1] |
 | 3-(3,4-Dichlorophenyl)-1-(2-(3,5-diphenyl-1H-pyrazol-1-yl)-4-methylthiazol-5-yl)prop-2-en-1-one | IC50 | 4900.0 [1] |
 | N-[2-(6-Methoxynaphthalen-1-yl)ethyl]cyclobutanecarboxamide | IC50 | 70.79 [1] |
 | Rac-N-[2-(2,3-Dihydro-6-methoxy-1H-inden-1-yl)ethyl]propanamide | Ki | 686.0 [1] |
 | (Z)-3-(3,5-Dimethoxy-phenyl)-2-(4-methoxy-phenyl)-acrylonitrile | IC50 | 31600.0 [1] |
 | 5-Quinoxalinol, 6,8-dibromo-2,3-dimethyl- | IC50 | 2900.0 [1] |
 | 7,8-Dichloro-1-hydroxyphenazine | IC50 | 480.0 [1] |
 | 5-((3-Diethylamino)propyl)amino-8-hydroxy-6H-imidazo(4,5,1-de)acridin-6-one | IC50 | 597.0 [1] |
 | 10-[2-(Dimethylamino)ethylamino]-5-methoxy-15-methyl-1,14-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-2(7),3,5,9,11,13(16),14-heptaen-8-one | IC50 | 46.0 [1] |
 | (E)-4'-Amino-3,4,5-trimethoxystilbene | IC50 | 270.0 [1] |
Calculator
